GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Translational Development Acquisition Corp (NAS:TDACU) » Definitions » Interest Expense

Translational Development Acquisition (Translational Development Acquisition) Interest Expense : $ Mil (TTM As of May. 2022)


View and export this data going back to 2022. Start your Free Trial

What is Translational Development Acquisition Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Translational Development Acquisition's interest expense for the six months ended in May. 2022 was $ 0.00 Mil. Translational Development Acquisition does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in May. 2022.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Translational Development Acquisition's Operating Income for the six months ended in May. 2022 was $ 0.00 Mil. Translational Development Acquisition's Interest Expense for the six months ended in May. 2022 was $ 0.00 Mil. GuruFocus does not calculate Translational Development Acquisition's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Translational Development Acquisition Interest Expense Historical Data

The historical data trend for Translational Development Acquisition's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Translational Development Acquisition Interest Expense Chart

Translational Development Acquisition Annual Data
Trend
Interest Expense

Translational Development Acquisition Semi-Annual Data
May22
Interest Expense -

Translational Development Acquisition Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.


Translational Development Acquisition  (NAS:TDACU) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Translational Development Acquisition's Interest Expense for the six months ended in May. 2022 was $0.00 Mil. Its Operating Income for the six months ended in May. 2022 was $0.00 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in May. 2022 was $0.08 Mil.

Translational Development Acquisition's Interest Coverage for the quarter that ended in May. 2022 is calculated as

GuruFocus does not calculate Translational Development Acquisition's interest coverage with the available data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


Translational Development Acquisition (Translational Development Acquisition) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
1270 Avenue of the Americas, 24th Floor, New York, NY, USA, 10020
Website
Translational Development Acquisition Corp is a newly organized blank check company.